טוען...
Altered Fc galactosylation in IgG(4) is a potential serum marker for chronic lung disease
Characterising chronic lung diseases is challenging. New, less invasive diagnostics are needed to decipher disease pathologies and subphenotypes. Fc galactosylation is known to affect IgG function, and is altered in autoimmune disorders and under other pathological conditions. We tested how well Fc...
שמור ב:
| הוצא לאור ב: | ERJ Open Res |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
European Respiratory Society
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6066530/ https://ncbi.nlm.nih.gov/pubmed/30083550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00033-2018 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|